Literature DB >> 2305012

Changes in seizure threshold and aggression during chronic treatment with three anticonvulsants and on drug withdrawal.

S E File1, L J Wilks.   

Abstract

Sodium phenobarbitone (20 and 70 mg/kg) had a significant anticonvulsant action against pentylenetetrazole-induced seizures, which persisted for 21 days of treatment. On drug withdrawal there was a significant decrease in seizure threshold below control level 24-48 h after the last dose of 70 mg/kg. Phenytoin (40 mg/kg) had a significant anticonvulsant action after 7 days of treatment and this persisted for 21 days of treatment. On drug withdrawal there was a significant decrease in seizure threshold 48 h after the last dose. Lorazepam (0.1 mg/kg) had a significant anticonvulsant action, but the group tested after 21 days of treatment did not differ from the controls, indicating that tolerance had developed to this effect; on drug withdrawal there was a decrease in seizure threshold from 24 to 72 h. The only drug to increase aggressive behaviour was sodium phenobarbitone (70 mg/kg); this reached significance after 14 and 21 days of treatment and occurred 8 h after drug administration; 0.5 h after drug administration phenobarbitone (70 mg/kg) abolished aggressive behaviour. After 7 days of treatment phenobarbitone (70 mg/kg) increased social behaviour 0.5 h after administration and this was still increased after 21 days of treatment. On drug withdrawal, there were no changes in aggressive behaviour, but there were significant decreases in social behaviour 24 and 48 h after phenobarbitone (70 mg/kg) withdrawal and 24, 48 and 72 h after lorazepam (0.1 mg/kg) withdrawal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305012     DOI: 10.1007/bf02244413

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

Review 1.  Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Authors:  H Kalant; A E LeBlanc; R J Gibbins
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

2.  Anticonvulsant effects of chronic treatment with phenytoin against pentylenetetrazole-induced seizures in the mouse.

Authors:  S E File; S Pellow; L Wilks
Journal:  Neuropharmacology       Date:  1985-10       Impact factor: 5.250

3.  The role of the benzodiazepine receptor in mediating long-lasting anticonvulsant effects and the late-appearing reductions in motor activity and exploration.

Authors:  S E File; L J Wilks; P S Mabbutt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Anticonvulsant properties of 5-phenyl-5-ethyl-hexahydropyrimidine-4,6-dione (mysoline), a new antiepileptic.

Authors:  L S GOODMAN; E A SWINYARD; W C BROWN; D O SCHIFFMAN; M S GREWAL; E L BLISS
Journal:  J Pharmacol Exp Ther       Date:  1953-08       Impact factor: 4.030

Review 5.  Clonazepam. A review of a new anticonvulsant drug.

Authors:  T R Browne
Journal:  Arch Neurol       Date:  1976-05

Review 6.  Current status of the 1,4- and 1,5-benzodiazepines in the treatment of epilepsy: the place of clobazam.

Authors:  M M Robertson
Journal:  Epilepsia       Date:  1986       Impact factor: 5.864

7.  Methods for the determination of lorazepam and chlordiazepoxide and metabolites in brain tissue. A comparison with plasma concentrations in the rat.

Authors:  R G Lister; D R Abernethy; D J Greenblatt; S E File
Journal:  J Chromatogr       Date:  1983-10-14

8.  Withdrawal, tolerance and sensitization after a single dose of lorazepam.

Authors:  S E File; L J Wilks; P S Mabbutt
Journal:  Pharmacol Biochem Behav       Date:  1988-12       Impact factor: 3.533

9.  Evidence for simultaneous anxiolytic and aversive effects several hours after administration of sodium phenobarbitone to the rat.

Authors:  L J Wilks; S E File
Journal:  Neuropsychobiology       Date:  1988       Impact factor: 2.328

10.  Optimizing the pentetrazol infusion test for seizure threshold measurement.

Authors:  D J Nutt; S C Taylor; H J Little
Journal:  J Pharm Pharmacol       Date:  1986-09       Impact factor: 3.765

View more
  2 in total

1.  Prenatal effects of antiepileptic drugs.

Authors:  Chrysanthy Ikonomidou
Journal:  Epilepsy Curr       Date:  2010-03       Impact factor: 7.500

2.  Ethosuximide Reduces Mortality and Seizure Severity in Response to Pentylenetetrazole Treatment During Ethanol Withdrawal.

Authors:  Melissa A Riegle; Melissa L Masicampo; Hong Qu Shan; Victoria Xu; Dwayne W Godwin
Journal:  Alcohol Alcohol       Date:  2015-04-12       Impact factor: 2.826

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.